Emergent BioSolutions Inc (NYSE:EBS)
$ 10.69 -0.2 (-1.84%) Market Cap: 579.23 Mil Enterprise Value: 1.38 Bil PE Ratio: 0 PB Ratio: 1.46 GF Score: 63/100

Q4 2023 Emergent BioSolutions Inc Earnings Call Transcript

Mar 06, 2024 / 10:00PM GMT
Release Date Price: $3.26 (-4.40%)
Operator

Good afternoon, everyone. I'm the operator for today's call. Thank you for joining today as Emergent discusses their operation and financial results for the fourth quarter and full year. As is customary today's call is open to all participants and the call is being recorded and is copyrighted by Emergent BioSolutions. In addition to today's press release, there is a series of slides accompanying this webcast available to all webcast participants.

Turning to Slide 3. During today's call, Emergent may make projections and other forward-looking statements related to their business. Future events are prospects for future performance. These forward-looking statements are based on their current intentions, beliefs and expectations regarding future events. Any forward-looking statements occurs only as today of this conference call and as expected, by required by law.

Emergent does not undertake to update any forward-looking statement to reflect new information, events or circumstances. Investors should consider this cautionary statement as well as risk factors identified in emergent periodic

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot